Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Attend Cantech Investment Conference 2019, January 29-30 in Toronto
Summit will highlight 100+ leading technology firms in the international cannabinoid-derived pharmaceuticals space; more than 3,500 investors are expected to attend LXRP is a drug delivery platform innovator with a growing IP portfolio of 10 patents granted and more than 50 patents filed globally LXRP out-licenses its delivery technology, such as its proprietary DehydraTECH; it holds a patent for oral delivery of all cannabinoids Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), a drug delivery platform innovator, will exhibit at the Cantech Investment Conference 2019, taking place on January 29-30 in Toronto, and it will participate in a specialized event where…